Immune activation in severe heart failure: Does etiology play a role?

European Heart Journal, Supplement

Volumn 6, Issue 6, 2004, Pages

  Agnoletti, Laura ^a   Curello, Salvatore ^b   Malacarne, Fabio ^c   Airò, Paolo ^c   Cargnoni, Anna ^a   Valgimigli, Marco ^d   Ferrari, Roberto ^d  

^a IRCCS   (Italy)

^b Spedali Civili   (Italy)

^c Immunology Department   (Italy)

^d S Maugeri Found IRCCS Univ F   (Italy)

Author keywords

Congestive heart failure; Immune system activation; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DISEASE COURSE; HEART FAILURE; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTOPOIESIS; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 8644260190     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehjsup.2004.09.014     Document Type: Article

References (42)

1. C.J. Limas Autoimmunity in dilated cardiomyopathy and the major histocompatibility complex Intern J Cardiol 54 1996 113 116
2. S.D. Anker, and M. Rauchhaus Insight into the pathogenesis of chronic heart failure: immune activation and cachexia Curr Opin Cardiol 14 1999 211 216
3. J.B. Marriot Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives Heart 75 1996 287 290
4. S. Hwang, T.J. Harris, and N.W Wilson Immune function in patients with chronic stable congestive heart failure Am Heart J 125 1993 1651 1658
5. K. Ebnet, and D. Vestweber Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines Histochem Cell Biol 112 1999 1 23
6. M. Fabbri, E. Bianchi, and L. Fumagalli Regulation of lymphocytee traffic by adhesion molecules Inflamm Res 48 1999 239 246
7. T.A. Manolio, K.L. Baughman, and R. Rodeheffer Prevalence andaetiology of idiopathic dilated cardiomyopathy (summary of NationalHeart, Lung, and Blood Institute workshop) Am J Cardiol 69 1992 1458 1466
8. L. Agnoletti, S. Curello, and T. Bachetti Serum from patients with severe heart failure downregulates eNOS and is proapoptotic. Role of tumor necrosis factor-α Circulation 100 1999 1983 1991
9. I. Vermes, C. Haanen, and H. Steffens-Nakken A novel assay for apoptosis flow cytometry detection of phosphatydylserine expression on early apoptotic cells using fluorescein labeled annexin V J Immunol Meth 184 1995 39 51
10. R.F. Vogst, G.D. Cross, and L.O. Henderson Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity of flow cytometers Cytometry 10 1989 294 301
11. O.H. Lowry, N.J. Rosenbrough, and A.L. Farr Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
12. E.A. Jaffe, L. Nachman, and C.G. Becker Culture of human endothelial cells derived derived from umbilical veins J Clin Invest 52 1973 2745 2756
13. I. Nicoletti, G. Migliorati, and M.C. Pagliacci A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J Immunol Meth 139 1991 271 279
14. S.R. Ommen, D.O. Hodge, and R.J. Rodeheffer Predictive power of the relative lymphocyte concentration in patients with advanced heart failure Circulation 97 1998 19 22
15. S.R. Kapadia Cytokines and heart failure Cardiol Rev 7 4 1999 196 206
16. S.K. Das, J.T. Cassidy, and R.E. Petty Antibodies against heart muscle and nuclear constituents in cardiomyopathy Am Heart J 83 1972 159 166
17. C. Holzinger, Andrea Schöllammer, and M. Imhof Phenotypic patterns of mononuclear cells in dilated cardiomyopathy Circulation 92 1995 2876 2885
18. D.T. Chao, and S.J. Korsmeyer BCL-2 family: regulators of cell death Annu Rev Immunol 16 1998 395 419
19. A. Strasser, A.W. Harris, and D.C.S. Huang Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis EMBO J 14 1996 6136 6147
20. L. Van Parijs, A. Ibramighov, and A.K. Abbas The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance Immunity 4 1996 321 328
21. M. Salmon, and D. Pilling The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis Eur J Immunol 24 1994 892 899
22. T. Brunner, R.J. Mogil, and D. LaFace Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas Nature 373 1995 441 444
23. S.T. Ju, D.J. Panka, and H. Cui Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation Nature 373 1995 444 448
24. T. Miyawaki, T. Uehara, and R. Nibu Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood J Immunol 149 1992 3753 3758
25. B.C. Trauth, C. Klas, and A.M. Peters Monoclonal antibody-mediated tumor regression by induction of apoptosis Science 245 1989 301 305
26. J. Dhein, P.T. Daniel, and B. Trauth Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens J Immunol 149 1992 3166 3173
27. T. Suda, T. Takahashi, and P. Golstein Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 6 1993 1169 1178
28. T. Suda, and S. Nagata Purification and characterization of the Fas-ligand that induces apoptosis J Exp Med 179 1994 873 879
29. S. Wesselborg, O. Janssen, and D. Kabelitz Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells J Immunol 150 1993 4338 4345
30. J. Estaquier, M. Tanaka, and T. Suda Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists Blood 87 1996 4959 4966
31. H. Kaneko, K. Saito, and H. Hashimoto Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis Clin Exp Immunol 106 1996 218 229
32. D. Brugnoni, P. Airò, and M. Pennacchio Immune reconstitution after bone marrow transplantation for combined imunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death Bone Marrow Transpl 23 1999 451 457
33. J. Laurence, D. Mitra, and M. Steiner Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia J Clin Invest 97 1996 672 680
34. D. Brugnoni, P. Airo', and F. Facchetti In vitro cell death of activated lymphocytes in Omenn's Syndrome Eur J Immunol 27 1997 2765 2773
35. Y. Seko, N. Takahashi, and S. Ishiyama Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy Circulation 97 1998 637 639
36. T.R. Ulich, J. del Castillo, and R.X. Ni Mechanisms of tumor necrosis alpha-induced lymphopenia, neutropenia and biphasic neutrophilia: a study of limphocyte recirculation and hematologic interaction of TNF-α with endogenous mediators of leukocyte trafficking J Leukoc Biol 45 1989 155 167
37. M.A. Opavsky, J. Penninger, and K. Aitken Susceptibility to myocarditis is dependent on the response of αβ T lymphocytes to coxackieviral infection Cir Res 85 1999 551 558
38. A. Bozkurt, A. Canatarough, and S. Cetiner Lymphocyte subsets in patients with idiopathic dilated cardiomyopathy Anadolu Kardiyol Derg 1 2 2001 98 100
39. S.D. Anker, K.R. Egerer, and H.D. Volk Elevated soluble CD14 receptors and altered cytokines in chronic heart failure Am J Cardiol 79 10 1997 1426 1430
40. M. Valgimigli, L. Agnoletti, and S. Curello Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells. A possible link to pan-coronary syndromes Circulation 107 2003 264 270
41. E.S. Chung, M. Packer, and K.H. Lo Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial Circulation 107 2003 3133 3140
42. W.V. Dörffel, S.B. Felix, and G. Wallukat Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy Circulation 95 1997 1994 1997